TrialJournal of clinical psychopharmacology2011

A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females.

A Eden Evins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.